…feature that distinguishes type I from type II anti-CD20 monoclonal antibodies (mAbs) and reduces their therapeutic efficacy is the tendency to internalize from the cell surface. We have shown previously that the extent of internalization correlates with the capacity of type I mA…

…mmobilized BSA or mouse Del-1 is shown in the absence (-) or in the presence of mAbs to CD51 (αv-integrin), to CD29 (β1-integrin), or to CD11a (LFA-1). Adhesion is presented as % adherent cells. Data are mean ± SD (n=3). **, P<0.01. (D) Adhesion of J-β 2 .7 transfectants expressi…

…hanced chemokine-directed migration; such effects could be inhibited by cirmtuzumab, a humanized anti-ROR1 mAb. We generated truncated forms of ROR1 and found its extracellular cysteine-rich domain or kringle domain was necessary for Wnt5a-induced HS1 phosphorylation. Moreover, t…

Abstract Therapeutic monoclonal immunoglobulins (mAbs) are used to treat patients with a wide range of disorders including autoimmune diseases. As pharmaceutical companies bring more fully humanized therapeutic mAb drugs to the healthcare market analytical platforms that perform …

…te reference (Shelley) or as an inspiration (Tolkien). Thus, in Shelley’s Queen Mab we read: Beside the eternal Nile, The Pyramids have risen. Nile shall pursue his changeless way: Those pyramids shall fall… (Shelley 2009: 21, ll. 126–129). Previously in the same poem, the ruined…

…oniche della biofiction, dentro e fuori la metafinzione Il mondo ‘possibile’ di Mab’s Daughters Abstract in italiano: Lo studio attira l’attenzione sulle molteplici possibilità interpretative delle biofiction, finzioni che assumono come protagoniste una o più figure del passato. …

Background: Vaccination during pregnancy and infant monoclonal antibodies (mAb) were recently approved to prevent respiratory syncytial virus (RSV) disease in infants. Our study aims to describe self-reported attitudes and preferences between vaccination during pregnancy and infa…

…in (amino acids 489–744) was used to im- munize mice and a monoclonal antibody (mAb X3T-3A6) was prepared For immunofluorescence, fully confluent cells were split 1:2 onto cover- following standard methods (Harlow and Lane, 1988). slips and allowed to grow 24 h before fixation. C…

…lotting using a mouse monoclonal specific for the K1 Block 2 serotype of MSP-1 (mAb12.2, Fig. 2B [33] and with polyclonal sera raised against individual MSP-1 Block 2 recombinant proteins [33] (data not shown). The major soluble protein in the cell lysate was MSP-1 hybrid, with m…

… UTC Sono stati selezionati i vincitori del bando musei, archivi e biblioteche (MAB) 2026 di Wikimedia Italia. I nove progetti scelti quest’anno si distinguono per la varietà dei patrimoni coinvolti e per l’attenzione alla condivisione open access di materiali eterogenei: dalle c…

…is study examined whether therapy with a non-mitogenic, non-activating anti-CD3 mAb (G4.18) alone, or in combination with the T(h)2 cytokines, could inhibit induction or facilitate recovery from experimental allergic encephalomyelitis (EAE) in Lewis rats. G4.18, but not rIL-4, rI…

…ed with either secondary antibody alone (control, in black) or first with mouse mAbs (in gray) for α v β 3 (Axum-4), α v β 5 (Alula), α v β 6 (3G9), or α v β 8 (Adwa11), all generated by immunizing knockout mice with integrin subunits. (B) Co-IP and WB of cell lysates of isolated…

… acetone, permeabilized with TritonX-100, stained with Alexa-488-conjugated 1D4 mAb, and subjected to confocal microscopy. A ) Representative Alexa-488-conjugated 1D4 mAb fluorescent image resulting from IHC of an L4 TG animal expressing (h)Mo in neurons. 1D4 mAb stained the vent…

…c proteins, urinary albumin variants, charge variants of monoclonal antibodies (mAbs), and large-scale TDP of complex proteomes. Technical Development of cIEF-MS CE-MS Interface Online hyphenation of cIEF and ESI-MS requires a CE-MS interface that can establish electrical continu…

…r targeted therapies. UC-961 is a first-in-class humanized monoclonal antibody (mAb) that binds the extracellular domain of ROR1. In this paper we outline some of the preclinical studies leading to an investigation new drug (IND) designation, enabling clinical studies in patients…